REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 126 filers reported holding REVOLUTION MEDICINES INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,834,813 | -57.2% | 315,550 | -52.9% | 0.72% | -63.7% |
| Q4 2022 | $15,968,499 | +20.8% | 670,382 | 0.0% | 1.98% | +20.4% |
| Q3 2022 | $13,220,000 | +1.2% | 670,382 | 0.0% | 1.64% | +8.7% |
| Q2 2022 | $13,066,000 | -23.6% | 670,382 | 0.0% | 1.51% | -12.3% |
| Q1 2022 | $17,101,000 | +1.3% | 670,382 | 0.0% | 1.73% | +9.0% |
| Q4 2021 | $16,874,000 | -8.5% | 670,382 | 0.0% | 1.58% | +46.5% |
| Q3 2021 | $18,442,000 | -13.3% | 670,382 | 0.0% | 1.08% | -11.7% |
| Q2 2021 | $21,278,000 | -30.8% | 670,382 | 0.0% | 1.22% | -28.8% |
| Q1 2021 | $30,757,000 | +15.9% | 670,382 | 0.0% | 1.72% | +19.3% |
| Q4 2020 | $26,540,000 | +13.8% | 670,382 | 0.0% | 1.44% | +12.2% |
| Q3 2020 | $23,330,000 | +10.2% | 670,382 | 0.0% | 1.28% | -28.9% |
| Q2 2020 | $21,164,000 | +44.1% | 670,382 | 0.0% | 1.80% | -21.5% |
| Q1 2020 | $14,688,000 | – | 670,382 | – | 2.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |